

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, alternative pathway (GO:0006957) | 9.35148710 |
| 2 | exogenous drug catabolic process (GO:0042738) | 8.88183346 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 8.73630295 |
| 4 | epoxygenase P450 pathway (GO:0019373) | 8.61941078 |
| 5 | regulation of protein activation cascade (GO:2000257) | 8.35503649 |
| 6 | drug catabolic process (GO:0042737) | 8.25843747 |
| 7 | ethanol oxidation (GO:0006069) | 8.24396672 |
| 8 | regulation of complement activation (GO:0030449) | 8.14985726 |
| 9 | regulation of fibrinolysis (GO:0051917) | 7.38065729 |
| 10 | glyoxylate metabolic process (GO:0046487) | 7.13108578 |
| 11 | negative regulation of fibrinolysis (GO:0051918) | 6.85443164 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.67857393 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 6.67857393 |
| 14 | ethanol metabolic process (GO:0006067) | 6.58819774 |
| 15 | blood coagulation, intrinsic pathway (GO:0007597) | 6.17562267 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.09268031 |
| 17 | L-phenylalanine metabolic process (GO:0006558) | 6.09268031 |
| 18 | protein carboxylation (GO:0018214) | 6.01771271 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.01771271 |
| 20 | complement activation, classical pathway (GO:0006958) | 6.01514801 |
| 21 | drug metabolic process (GO:0017144) | 5.97615323 |
| 22 | * protein activation cascade (GO:0072376) | 5.97210991 |
| 23 | * complement activation (GO:0006956) | 5.92880514 |
| 24 | opsonization (GO:0008228) | 5.90444461 |
| 25 | urea metabolic process (GO:0019627) | 5.83847410 |
| 26 | negative regulation of protein activation cascade (GO:2000258) | 5.80344769 |
| 27 | fibrinolysis (GO:0042730) | 5.79177422 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.66869983 |
| 29 | imidazole-containing compound metabolic process (GO:0052803) | 5.50721921 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.38312007 |
| 31 | oxidative demethylation (GO:0070989) | 5.19279876 |
| 32 | regulation of humoral immune response (GO:0002920) | 5.15978068 |
| 33 | negative regulation of complement activation (GO:0045916) | 5.15772256 |
| 34 | regulation of plasminogen activation (GO:0010755) | 5.07280879 |
| 35 | acute-phase response (GO:0006953) | 5.03262862 |
| 36 | surfactant homeostasis (GO:0043129) | 5.00127629 |
| 37 | aromatic amino acid family catabolic process (GO:0009074) | 4.93646598 |
| 38 | urea cycle (GO:0000050) | 4.88853148 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 4.83774223 |
| 40 | bile acid biosynthetic process (GO:0006699) | 4.73255906 |
| 41 | cytolysis (GO:0019835) | 4.56682100 |
| 42 | negative regulation of hemostasis (GO:1900047) | 4.52422888 |
| 43 | negative regulation of blood coagulation (GO:0030195) | 4.52422888 |
| 44 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.48832676 |
| 45 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.48832676 |
| 46 | serine family amino acid catabolic process (GO:0009071) | 4.46651325 |
| 47 | negative regulation of sterol transport (GO:0032372) | 4.45283590 |
| 48 | negative regulation of cholesterol transport (GO:0032375) | 4.45283590 |
| 49 | cellular glucuronidation (GO:0052695) | 4.39539472 |
| 50 | phenylpropanoid metabolic process (GO:0009698) | 4.26985464 |
| 51 | bile acid metabolic process (GO:0008206) | 4.24224273 |
| 52 | glutamate metabolic process (GO:0006536) | 4.15649003 |
| 53 | negative regulation of humoral immune response (GO:0002921) | 4.15382838 |
| 54 | glucuronate metabolic process (GO:0019585) | 4.14529958 |
| 55 | uronic acid metabolic process (GO:0006063) | 4.14529958 |
| 56 | negative regulation of coagulation (GO:0050819) | 4.12773538 |
| 57 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.10311452 |
| 58 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.10311452 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.09796358 |
| 60 | triglyceride homeostasis (GO:0070328) | 4.09796358 |
| 61 | negative regulation of wound healing (GO:0061045) | 4.04677059 |
| 62 | chemical homeostasis within a tissue (GO:0048875) | 4.01434057 |
| 63 | tyrosine metabolic process (GO:0006570) | 3.96227052 |
| 64 | plasma lipoprotein particle remodeling (GO:0034369) | 3.95090584 |
| 65 | protein-lipid complex remodeling (GO:0034368) | 3.95090584 |
| 66 | macromolecular complex remodeling (GO:0034367) | 3.95090584 |
| 67 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.93936016 |
| 68 | S-adenosylmethionine metabolic process (GO:0046500) | 3.91288289 |
| 69 | positive regulation of blood coagulation (GO:0030194) | 3.84828192 |
| 70 | positive regulation of hemostasis (GO:1900048) | 3.84828192 |
| 71 | glycine metabolic process (GO:0006544) | 3.83438456 |
| 72 | bile acid and bile salt transport (GO:0015721) | 3.82450780 |
| 73 | response to mercury ion (GO:0046689) | 3.79024604 |
| 74 | high-density lipoprotein particle remodeling (GO:0034375) | 3.66951620 |
| 75 | acute inflammatory response (GO:0002526) | 3.65979771 |
| 76 | regulation of acute inflammatory response (GO:0002673) | 3.61268108 |
| 77 | phospholipid efflux (GO:0033700) | 3.56184082 |
| 78 | cholesterol efflux (GO:0033344) | 3.54203860 |
| 79 | positive regulation of coagulation (GO:0050820) | 3.53748099 |
| 80 | alpha-amino acid catabolic process (GO:1901606) | 3.50262776 |
| 81 | regulation of apoptotic cell clearance (GO:2000425) | 3.47755814 |
| 82 | cellular ketone body metabolic process (GO:0046950) | 3.44178492 |
| 83 | sodium-independent organic anion transport (GO:0043252) | 3.44066714 |
| 84 | negative regulation of lipase activity (GO:0060192) | 3.39834818 |
| 85 | tryptophan catabolic process (GO:0006569) | 3.38792558 |
| 86 | indole-containing compound catabolic process (GO:0042436) | 3.38792558 |
| 87 | indolalkylamine catabolic process (GO:0046218) | 3.38792558 |
| 88 | reverse cholesterol transport (GO:0043691) | 3.35145638 |
| 89 | hormone catabolic process (GO:0042447) | 3.34615047 |
| 90 | alkaloid metabolic process (GO:0009820) | 3.32914177 |
| 91 | regulation of cholesterol esterification (GO:0010872) | 3.32477092 |
| 92 | arginine metabolic process (GO:0006525) | 3.31135175 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 3.22190290 |
| 94 | amino-acid betaine metabolic process (GO:0006577) | 3.19719151 |
| 95 | aromatic amino acid family metabolic process (GO:0009072) | 3.16910485 |
| 96 | xenobiotic metabolic process (GO:0006805) | 3.14311420 |
| 97 | primary alcohol metabolic process (GO:0034308) | 3.13222015 |
| 98 | phosphate ion transmembrane transport (GO:0035435) | 3.11796236 |
| 99 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.11405523 |
| 100 | plasma lipoprotein particle clearance (GO:0034381) | 3.09745775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.16485652 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.55638025 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.11087622 |
| 4 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.88087273 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.82444470 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.57168008 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.36330532 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.63237129 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.31045810 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.29584560 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.85226736 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.58091904 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.87579838 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.82688923 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.79067213 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.64408671 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59939335 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58180983 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54069028 |
| 20 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.48069986 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47311631 |
| 22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.46188434 |
| 23 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45026543 |
| 24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41706197 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.40038316 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36695747 |
| 27 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.25201939 |
| 28 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.25201939 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23865669 |
| 30 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.23656513 |
| 31 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23181723 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21784368 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.20951848 |
| 34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.20563185 |
| 35 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09126818 |
| 36 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03446036 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01587049 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00617955 |
| 39 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99664331 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98729745 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94612200 |
| 42 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93065429 |
| 43 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92628947 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92291830 |
| 45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92098881 |
| 46 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.91001723 |
| 47 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90087804 |
| 48 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88620287 |
| 49 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88618931 |
| 50 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87705650 |
| 51 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.87453559 |
| 52 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84530615 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83290664 |
| 54 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82675681 |
| 55 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81841666 |
| 56 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81194006 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80797255 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80790513 |
| 59 | CBP_21632823_ChIP-Seq_H3396_Human | 0.80340254 |
| 60 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79188388 |
| 61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77482758 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77038486 |
| 63 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74477391 |
| 64 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.74421814 |
| 65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.72561701 |
| 66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.71805332 |
| 67 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71077129 |
| 68 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.69474296 |
| 69 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.68522908 |
| 70 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68494055 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.67611750 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.66737177 |
| 73 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.66472471 |
| 74 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.64486552 |
| 75 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.63517639 |
| 76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.62694853 |
| 77 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.62554570 |
| 78 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.61259418 |
| 79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.60652517 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 0.59307883 |
| 81 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.59109170 |
| 82 | CJUN_26792858_Chip-Seq_BT549_Human | 0.58884335 |
| 83 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.58864015 |
| 84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58864015 |
| 85 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.58757208 |
| 86 | NFYA_21822215_ChIP-Seq_K562_Human | 0.58678430 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58319811 |
| 88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.57913624 |
| 89 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.57650368 |
| 90 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.57391104 |
| 91 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.56804383 |
| 92 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.55093016 |
| 93 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.54970086 |
| 94 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.54087723 |
| 95 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.53605814 |
| 96 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.53472019 |
| 97 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53458878 |
| 98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.53114809 |
| 99 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53022055 |
| 100 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.52814815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.38543460 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 5.38209695 |
| 3 | MP0005360_urolithiasis | 5.19182944 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.07761752 |
| 5 | MP0005365_abnormal_bile_salt | 4.34208864 |
| 6 | MP0003195_calcinosis | 4.31502135 |
| 7 | MP0010368_abnormal_lymphatic_system | 4.10296362 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 4.04152889 |
| 9 | MP0004782_abnormal_surfactant_physiolog | 3.42962175 |
| 10 | MP0003252_abnormal_bile_duct | 3.11315923 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 3.00753870 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.43365730 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.28853203 |
| 14 | MP0005670_abnormal_white_adipose | 2.21233216 |
| 15 | MP0005332_abnormal_amino_acid | 2.19698241 |
| 16 | MP0003868_abnormal_feces_composition | 2.12999981 |
| 17 | MP0009840_abnormal_foam_cell | 2.09560900 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.72961052 |
| 19 | MP0001958_emphysema | 1.65109211 |
| 20 | MP0004084_abnormal_cardiac_muscle | 1.63686812 |
| 21 | MP0009697_abnormal_copulation | 1.62932503 |
| 22 | MP0000609_abnormal_liver_physiology | 1.55655642 |
| 23 | MP0004272_abnormal_basement_membrane | 1.54632108 |
| 24 | MP0006138_congestive_heart_failure | 1.49906239 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.45464780 |
| 26 | MP0005451_abnormal_body_composition | 1.34239333 |
| 27 | MP0001661_extended_life_span | 1.33613332 |
| 28 | MP0001879_abnormal_lymphatic_vessel | 1.26768826 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.19557101 |
| 30 | MP0002295_abnormal_pulmonary_circulatio | 1.17789482 |
| 31 | MP0005330_cardiomyopathy | 1.17266512 |
| 32 | MP0002132_abnormal_respiratory_system | 1.17100708 |
| 33 | MP0002332_abnormal_exercise_endurance | 1.15046221 |
| 34 | MP0002971_abnormal_brown_adipose | 1.09741503 |
| 35 | MP0004036_abnormal_muscle_relaxation | 1.08454699 |
| 36 | MP0004215_abnormal_myocardial_fiber | 1.08248885 |
| 37 | MP0003828_pulmonary_edema | 1.07970357 |
| 38 | MP0000249_abnormal_blood_vessel | 1.05248916 |
| 39 | MP0009764_decreased_sensitivity_to | 1.04058369 |
| 40 | MP0009763_increased_sensitivity_to | 1.03194133 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.02953818 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.02394523 |
| 43 | MP0004130_abnormal_muscle_cell | 1.01610028 |
| 44 | MP0008775_abnormal_heart_ventricle | 1.00764950 |
| 45 | MP0002133_abnormal_respiratory_system | 0.99145159 |
| 46 | MP0005388_respiratory_system_phenotype | 0.99145159 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98873585 |
| 48 | MP0005385_cardiovascular_system_phenoty | 0.98473757 |
| 49 | MP0001544_abnormal_cardiovascular_syste | 0.98473757 |
| 50 | MP0009053_abnormal_anal_canal | 0.97652941 |
| 51 | MP0001764_abnormal_homeostasis | 0.97123479 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 0.96733538 |
| 53 | MP0005165_increased_susceptibility_to | 0.95740305 |
| 54 | MP0001915_intracranial_hemorrhage | 0.95292133 |
| 55 | MP0005595_abnormal_vascular_smooth | 0.94105307 |
| 56 | MP0004883_abnormal_blood_vessel | 0.91971181 |
| 57 | MP0008004_abnormal_stomach_pH | 0.91613245 |
| 58 | MP0000751_myopathy | 0.90644414 |
| 59 | MP0005164_abnormal_response_to | 0.89238265 |
| 60 | MP0002837_dystrophic_cardiac_calcinosis | 0.88462432 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 0.87696753 |
| 62 | MP0005376_homeostasis/metabolism_phenot | 0.87670453 |
| 63 | MP0003690_abnormal_glial_cell | 0.87613483 |
| 64 | MP0000598_abnormal_liver_morphology | 0.86746229 |
| 65 | MP0005023_abnormal_wound_healing | 0.86363060 |
| 66 | MP0001851_eye_inflammation | 0.84354351 |
| 67 | MP0005535_abnormal_body_temperature | 0.83213116 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 0.82546647 |
| 69 | MP0003724_increased_susceptibility_to | 0.81611811 |
| 70 | MP0005083_abnormal_biliary_tract | 0.80877656 |
| 71 | MP0004019_abnormal_vitamin_homeostasis | 0.78864320 |
| 72 | MP0003566_abnormal_cell_adhesion | 0.77024685 |
| 73 | MP0000604_amyloidosis | 0.76897600 |
| 74 | MP0002168_other_aberrant_phenotype | 0.74932613 |
| 75 | MP0008995_early_reproductive_senescence | 0.74738588 |
| 76 | MP0009642_abnormal_blood_homeostasis | 0.74576942 |
| 77 | MP0002128_abnormal_blood_circulation | 0.74047849 |
| 78 | MP0005334_abnormal_fat_pad | 0.72347773 |
| 79 | MP0005397_hematopoietic_system_phenotyp | 0.71319871 |
| 80 | MP0001545_abnormal_hematopoietic_system | 0.71319871 |
| 81 | MP0005266_abnormal_metabolism | 0.70202271 |
| 82 | MP0008469_abnormal_protein_level | 0.68169470 |
| 83 | MP0002972_abnormal_cardiac_muscle | 0.67042950 |
| 84 | MP0005666_abnormal_adipose_tissue | 0.66730478 |
| 85 | MP0001542_abnormal_bone_strength | 0.65684752 |
| 86 | MP0005408_hypopigmentation | 0.65580270 |
| 87 | MP0000343_altered_response_to | 0.65284686 |
| 88 | MP0010630_abnormal_cardiac_muscle | 0.64911338 |
| 89 | MP0005166_decreased_susceptibility_to | 0.63922035 |
| 90 | MP0003075_altered_response_to | 0.63499352 |
| 91 | MP0002282_abnormal_trachea_morphology | 0.63189932 |
| 92 | MP0004484_altered_response_of | 0.62408984 |
| 93 | MP0005464_abnormal_platelet_physiology | 0.59520117 |
| 94 | MP0008874_decreased_physiological_sensi | 0.58238479 |
| 95 | MP0009785_altered_susceptibility_to | 0.56614980 |
| 96 | MP0003011_delayed_dark_adaptation | 0.56065563 |
| 97 | MP0004510_myositis | 0.55041766 |
| 98 | MP0002078_abnormal_glucose_homeostasis | 0.54763528 |
| 99 | MP0005187_abnormal_penis_morphology | 0.53536093 |
| 100 | MP0003186_abnormal_redox_activity | 0.53268894 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of complement system (HP:0005339) | 9.30315411 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 8.56208600 |
| 3 | Deep venous thrombosis (HP:0002625) | 8.37745051 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 7.86841118 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 7.65491791 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.16124349 |
| 7 | Joint hemorrhage (HP:0005261) | 6.39100757 |
| 8 | Glomerulonephritis (HP:0000099) | 5.91279762 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 5.76287665 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.64916475 |
| 11 | Conjugated hyperbilirubinemia (HP:0002908) | 5.62183106 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.62140509 |
| 13 | Xanthomatosis (HP:0000991) | 4.69950170 |
| 14 | Nephritis (HP:0000123) | 4.42079730 |
| 15 | Abnormality of the intrinsic pathway (HP:0010989) | 4.39573923 |
| 16 | Interstitial pulmonary disease (HP:0006530) | 4.35072032 |
| 17 | Intrahepatic cholestasis (HP:0001406) | 4.27039694 |
| 18 | Spontaneous abortion (HP:0005268) | 4.14213078 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.91305401 |
| 20 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.86339101 |
| 21 | Hypolipoproteinemia (HP:0010981) | 3.73801610 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.55360551 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.43856155 |
| 24 | Vascular calcification (HP:0004934) | 2.90895145 |
| 25 | Hemorrhage of the eye (HP:0011885) | 2.89929912 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 2.85357499 |
| 27 | Epidermoid cyst (HP:0200040) | 2.83735690 |
| 28 | Neonatal hypoglycemia (HP:0001998) | 2.79895209 |
| 29 | Delayed CNS myelination (HP:0002188) | 2.76161883 |
| 30 | Thrombophlebitis (HP:0004418) | 2.74366758 |
| 31 | Myocardial infarction (HP:0001658) | 2.72872132 |
| 32 | Atrioventricular block (HP:0001678) | 2.71802345 |
| 33 | Purpura (HP:0000979) | 2.64979864 |
| 34 | Mitral stenosis (HP:0001718) | 2.64011248 |
| 35 | Gingival bleeding (HP:0000225) | 2.63153104 |
| 36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.62881489 |
| 37 | Cardiovascular calcification (HP:0011915) | 2.59824209 |
| 38 | Fat malabsorption (HP:0002630) | 2.51302803 |
| 39 | Hypercholesterolemia (HP:0003124) | 2.49395010 |
| 40 | Hyperammonemia (HP:0001987) | 2.48080531 |
| 41 | Skin nodule (HP:0200036) | 2.38391756 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.37461435 |
| 43 | Fair hair (HP:0002286) | 2.32358452 |
| 44 | Pulmonary embolism (HP:0002204) | 2.29577582 |
| 45 | Esophageal varix (HP:0002040) | 2.27777393 |
| 46 | Polycythemia (HP:0001901) | 2.24795804 |
| 47 | Hyperglycinemia (HP:0002154) | 2.21267943 |
| 48 | Menorrhagia (HP:0000132) | 2.20355016 |
| 49 | Abnormality of nucleobase metabolism (HP:0010932) | 2.19145529 |
| 50 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.15228573 |
| 51 | Joint swelling (HP:0001386) | 2.08741214 |
| 52 | Cerebral palsy (HP:0100021) | 2.08146417 |
| 53 | Rickets (HP:0002748) | 2.08042816 |
| 54 | Generalized aminoaciduria (HP:0002909) | 2.07506137 |
| 55 | Abnormality of glycine metabolism (HP:0010895) | 2.05479346 |
| 56 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.05479346 |
| 57 | Osteomalacia (HP:0002749) | 2.04657369 |
| 58 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.04260959 |
| 59 | Steatorrhea (HP:0002570) | 2.01751458 |
| 60 | Complement deficiency (HP:0004431) | 11.3875929 |
| 61 | Hyperbilirubinemia (HP:0002904) | 1.98987801 |
| 62 | Respiratory distress (HP:0002098) | 1.98901228 |
| 63 | Abnormal atrioventricular conduction (HP:0005150) | 1.98595046 |
| 64 | Heart block (HP:0012722) | 1.97401833 |
| 65 | Hepatocellular carcinoma (HP:0001402) | 1.93465373 |
| 66 | Visceral angiomatosis (HP:0100761) | 1.92274608 |
| 67 | Tachypnea (HP:0002789) | 1.90773951 |
| 68 | Epistaxis (HP:0000421) | 1.89819839 |
| 69 | Abnormality of iron homeostasis (HP:0011031) | 1.82016362 |
| 70 | Blue irides (HP:0000635) | 1.80230779 |
| 71 | Metabolic acidosis (HP:0001942) | 1.78290272 |
| 72 | Hemangiomatosis (HP:0007461) | 1.77855152 |
| 73 | Abnormality of serum amino acid levels (HP:0003112) | 1.77394319 |
| 74 | Ketosis (HP:0001946) | 1.75000041 |
| 75 | Stroke (HP:0001297) | 1.73954105 |
| 76 | Amyloidosis (HP:0011034) | 1.73438248 |
| 77 | Generalized hypopigmentation of hair (HP:0011358) | 1.71568239 |
| 78 | Conjunctival telangiectasia (HP:0000524) | 1.71511961 |
| 79 | Lymphangioma (HP:0100764) | 1.69911528 |
| 80 | Cholelithiasis (HP:0001081) | 1.69659715 |
| 81 | Hyperglycinuria (HP:0003108) | 1.64260948 |
| 82 | Sudden death (HP:0001699) | 1.62981122 |
| 83 | Abnormal platelet function (HP:0011869) | 1.60261398 |
| 84 | Impaired platelet aggregation (HP:0003540) | 1.60261398 |
| 85 | Abnormal gallbladder morphology (HP:0012437) | 1.56531688 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.56380237 |
| 87 | Increased serum ferritin (HP:0003281) | 1.54300531 |
| 88 | Hypertriglyceridemia (HP:0002155) | 1.52960741 |
| 89 | Elevated alkaline phosphatase (HP:0003155) | 1.50491065 |
| 90 | Gout (HP:0001997) | 1.49003029 |
| 91 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.48188015 |
| 92 | Increased mean platelet volume (HP:0011877) | 1.48010355 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 1.47631510 |
| 94 | Gangrene (HP:0100758) | 1.42581711 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 1.42515142 |
| 96 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.42217569 |
| 97 | Abnormality of the fingertips (HP:0001211) | 1.41085508 |
| 98 | Hypophosphatemic rickets (HP:0004912) | 1.40946073 |
| 99 | Asymmetric septal hypertrophy (HP:0001670) | 1.40482554 |
| 100 | Abnormal gallbladder physiology (HP:0012438) | 1.39996528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.78703163 |
| 2 | KDR | 4.57633771 |
| 3 | ERN1 | 3.53419782 |
| 4 | TGFBR2 | 3.27917165 |
| 5 | MYLK | 3.24884518 |
| 6 | EPHA3 | 3.08252386 |
| 7 | RIPK1 | 2.89799085 |
| 8 | FGFR4 | 2.87341194 |
| 9 | TRIB3 | 2.29885775 |
| 10 | FER | 2.25748364 |
| 11 | EPHB1 | 2.18956086 |
| 12 | TTN | 1.93973026 |
| 13 | MAP3K6 | 1.64429024 |
| 14 | NLK | 1.45480650 |
| 15 | PRPF4B | 1.43784125 |
| 16 | PRKAA2 | 1.36196752 |
| 17 | PDPK1 | 1.34138245 |
| 18 | EPHB2 | 1.32693870 |
| 19 | CDC42BPA | 1.32262662 |
| 20 | MAP3K3 | 1.32098155 |
| 21 | TYK2 | 1.26699642 |
| 22 | FGFR3 | 1.23405252 |
| 23 | PRKD1 | 1.19450985 |
| 24 | MST1R | 1.19186099 |
| 25 | NEK9 | 1.18094213 |
| 26 | SIK1 | 1.17044179 |
| 27 | MAPK12 | 1.16290332 |
| 28 | PRKACG | 1.13721462 |
| 29 | ZAP70 | 1.13261313 |
| 30 | PDK2 | 1.10635623 |
| 31 | JAK1 | 1.07268457 |
| 32 | OBSCN | 1.04159661 |
| 33 | PIK3CG | 1.01150283 |
| 34 | DMPK | 0.96621844 |
| 35 | FES | 0.94063867 |
| 36 | NTRK3 | 0.88280314 |
| 37 | LRRK2 | 0.88224704 |
| 38 | MAPK15 | 0.87118775 |
| 39 | MET | 0.85728750 |
| 40 | TRPM7 | 0.85622902 |
| 41 | IGF1R | 0.85048086 |
| 42 | AKT3 | 0.82635013 |
| 43 | MAP3K1 | 0.82626712 |
| 44 | MAPK7 | 0.78446914 |
| 45 | PIK3CA | 0.78179559 |
| 46 | IRAK1 | 0.77173786 |
| 47 | PKN2 | 0.76790398 |
| 48 | MAPK4 | 0.73334071 |
| 49 | RPS6KA2 | 0.70471400 |
| 50 | SGK2 | 0.69397594 |
| 51 | SGK3 | 0.67623231 |
| 52 | MAP3K13 | 0.67246911 |
| 53 | TBK1 | 0.67190914 |
| 54 | ROCK1 | 0.66552442 |
| 55 | PAK3 | 0.66105347 |
| 56 | BCKDK | 0.65193969 |
| 57 | PRKG1 | 0.65032737 |
| 58 | PDGFRA | 0.63375926 |
| 59 | ABL2 | 0.61578679 |
| 60 | CSK | 0.61465275 |
| 61 | MARK2 | 0.61360710 |
| 62 | DAPK2 | 0.61082904 |
| 63 | MAP3K7 | 0.60431812 |
| 64 | RET | 0.59534980 |
| 65 | JAK2 | 0.55736362 |
| 66 | EPHA2 | 0.55494234 |
| 67 | PDK1 | 0.54354009 |
| 68 | GSK3A | 0.53442586 |
| 69 | MAP2K3 | 0.53205285 |
| 70 | PRKACA | 0.53109993 |
| 71 | PRKCE | 0.52915129 |
| 72 | SGK494 | 0.52367433 |
| 73 | SGK223 | 0.52367433 |
| 74 | NTRK1 | 0.52018067 |
| 75 | LATS1 | 0.50012512 |
| 76 | PDGFRB | 0.49926720 |
| 77 | MAPKAPK3 | 0.49181752 |
| 78 | MOS | 0.48450905 |
| 79 | STK10 | 0.47978664 |
| 80 | ROCK2 | 0.47543387 |
| 81 | PRKACB | 0.46658811 |
| 82 | GRK7 | 0.46589540 |
| 83 | GRK5 | 0.46577102 |
| 84 | ERBB2 | 0.45813677 |
| 85 | DAPK3 | 0.45786816 |
| 86 | MAPK11 | 0.44164679 |
| 87 | CDK6 | 0.44152619 |
| 88 | PTK6 | 0.41004764 |
| 89 | RPS6KL1 | 0.39533925 |
| 90 | RPS6KC1 | 0.39533925 |
| 91 | PRKG2 | 0.38233387 |
| 92 | PRKAA1 | 0.36995518 |
| 93 | PAK4 | 0.34448763 |
| 94 | LMTK2 | 0.34354446 |
| 95 | MUSK | 0.33667777 |
| 96 | MAP3K5 | 0.32839595 |
| 97 | SRC | 0.32440475 |
| 98 | KSR2 | 0.31911528 |
| 99 | PRKCA | 0.30746331 |
| 100 | PINK1 | 0.30691824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.62058493 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.31140758 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.18794689 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.52169654 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.33903335 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.32931784 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.92163958 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.91098350 |
| 9 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.80133755 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.75549056 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.73534280 |
| 12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.70423889 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.64567204 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50226108 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.36280211 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19755857 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.12048872 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.05451057 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.01963753 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.00319949 |
| 21 | Prion diseases_Homo sapiens_hsa05020 | 1.95207804 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.93763515 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81989180 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.63472079 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.61490558 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.46173639 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40014030 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39819098 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.33956539 |
| 30 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.33801619 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29162610 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26401680 |
| 33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.17983715 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.13195091 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10347800 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07552380 |
| 37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.05568805 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05115825 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03984288 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 0.99957574 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99358566 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99322014 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95633022 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89765555 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 0.89206107 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83314561 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.83270405 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.81289246 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79065498 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.75031186 |
| 51 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66496232 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64301925 |
| 53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.60349356 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48560019 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 0.39517091 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 0.36361129 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 0.35421788 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34714845 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.33702262 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30354711 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29220570 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.28875524 |
| 63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.26856605 |
| 64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25512045 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.24253004 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.22107222 |
| 67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21771205 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20270340 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18722871 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.17860709 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16360662 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.15815681 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.15122872 |
| 74 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.13914192 |
| 75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.12080054 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.09639988 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.08804543 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.06988256 |
| 79 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06794092 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.03705115 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.03522997 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.02425303 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.1296021 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.1189203 |
| 85 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1157994 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1081510 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | -0.1033338 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.1027642 |
| 89 | Tight junction_Homo sapiens_hsa04530 | -0.0985228 |
| 90 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0820588 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | -0.0748060 |
| 92 | Phagosome_Homo sapiens_hsa04145 | -0.0687102 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | -0.0664004 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0607208 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | -0.0585508 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0554868 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0501163 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.0499969 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0312397 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0192374 |

